High Tower Advisors, LLC Fortress Biotech, Inc. Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.49 - $0.82 $20,188 - $33,784	-41,200 Reduced 48.53%	43,700 $24,000
Q1 2023 May 11, 2023	BUY	$0.65 - $1.1 $27,430 - $46,420	42,200 Added 98.83%	84,900 $69,000
Q4 2021 Feb 10, 2022	SELL	$2.42 - $3.65 $3,025 - $4,562	-1,250 Reduced 2.84%	42,700 $107,000
Q1 2021 May 10, 2021	SELL	$3.16 - $4.89 $90,850 - $140,587	-28,750 Reduced 39.55%	43,950 $155,000
Q4 2020 Feb 10, 2021	BUY	$2.2 - $4.45 $91,520 - $185,120	41,600 Added 133.76%	72,700 $231,000

Q3 2018 Nov 09, 2018	BUY	$1.44 - $3.13 $44,784 - $97,343	31,100 New	31,100 $50,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.